EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

ResolvedStocks

Health Canada Approves neffy as First Needle-Free Emergency Treatment for Anaphylaxis

First Detected: Apr 16, 2026, 5:01 AM
Last Update: 5 months ago
7 articles·6 stories

Event Summary

On April 16, Health Canada approved neffy as the first and only needle-free emergency treatment for anaphylaxis. This treatment is indicated for adults and children weighing 30 kg or more.

Timeline

CLINUVEL Showcases Peptide and Vitiligo Treatments at AAD 2026
Apr 16, 2026, 9:01 AMImpact: 4
Health Canada Approves neffy as First Needle-Free Emergency Treatment for Anaphylaxis
Apr 16, 2026, 5:01 AMImpact: 7

Price Impact

Since event start
SPRY-31.30%